AstraZeneca is to invest £120m in a new manufacturing facility in Macclesfield, Cheshire, to continue the production of injectable cancer treatment drugs.
The investment will secure 300 jobs manufacturing the Zoladex drug, and will see construction beginning this year, focusing
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
